tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Laaman, 35 are a HOLD (41.18%), 44 are a BUY (51.76%), 6 are a SELL (7.06%).
Analyst Sean Laaman, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 47.14% that have a potential upside of 16.9% achieved within 56 days.
Sean Laaman’s has documented 163 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HALO, Halozyme Therapeutics.
Analyst best performing recommendations are on RXRX (RECURSION PHARMACEUTICALS).
The best stock recommendation documented was for RXRX (RECURSION PHARMACEUTICALS) at 8/18/2025. The price target of $4.8 was fulfilled within 2 days with a profit of $0.72 (13.04%) receiving and performance score of 65.22.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Oct-2025
$250
$14.7 (6.25%)
$215
12 days ago
(30-Oct-2026)
4/6 (66.67%)
$20.06 (8.72%)
40
Buy Since 06-Feb-2024
$277
$41.7 (17.72%)
$267
12 days ago
(30-Oct-2026)
7/16 (43.75%)
$47.06 (20.47%)
144
Buy Since 30-Oct-2026
$288
$52.7 (22.40%)
$262
12 days ago
(30-Oct-2026)
27/35 (77.14%)
$58.06 (25.25%)
279
Hold Since 30-Oct-2026
$270
$34.7 (14.75%)
$235
12 days ago
(30-Oct-2026)
9/15 (60%)
$40.06 (17.42%)
60
Hold Since 19-Aug-2026
$230
$8 (3.60%)
2 months 24 days ago
(19-Aug-2026)
1/1 (100%)
$0.01 (0.00%)
2
Which stock is Sean Laaman most bullish on?
Which stock is Sean Laaman most reserved on?
What Year was the first public recommendation made by Sean Laaman?
